We aim to provide a critical assessment of the current literature, to address the impact of altered Arc expression on the molecular and cellular mechanisms underlying the functional neurophysiology in transgenic mouse models of AD-associated amyloidopathy. This evidence concerns the gene ARC and Alzheimer disease.